Micro-X Ltd. (MX1) AI Stock Analysis

• Market Cap: AU$30.02M
• Dividend Yield: N/A
• Average Volume (3M): 374.41K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.49
• Revenue Growth: -27.58%
• EPS Growth: 33.69%
• Country: AU
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 39
• Industry: Medical - Devices
• EPS (TTM): -0.02
• Shares Outstanding: 667,202,300
• 10 Day Avg. Volume: 361,775
• 30 Day Avg. Volume: 374,409
• PEG Ratio: 0.13
• Price to Book (P/B): 3.45
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -5.02
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$0.17
• Price Target Upside: 325.00% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 44 Neutral
• Price Target: AU$0.00 ▼(-100.00%Downside)

Micro-X Ltd.'s overall stock score is primarily impacted by its weak financial performance and bearish technical indicators. The company's inability to achieve profitability and its negative valuation metrics further contribute to a low stock score.

Micro-X Ltd. Business Overview & Revenue Model

Company Description

Micro-X Limited designs, develops, and manufactures lightweight carbon nano tube-based X-ray products for the healthcare and security imaging markets in Australia. The company offers rover veterinary, a mobile X-ray machine to diagnose and treat animals for general veterinarian practices; Carestream DRX Revolution Nano, a mobile X-ray imaging machine used for high intensity workflow diagnostic medical imaging in hospitals; and IED X-ray cameras. It also provides miniature baggage scanners to detect hidden threats concealed within passenger carry-on luggage; airport screening reimagined, a passenger self-screening airport checkpoint; and brain CT scanners for use in road and air ambulances. The company was incorporated in 2011 and is based in Tonsley, Australia.

How the Company Makes Money

Micro-X Ltd. generates revenue primarily through the sale of its advanced X-ray imaging products. The company's key revenue streams include direct sales to healthcare facilities, such as hospitals and clinics, and sales to government agencies and private enterprises in the security sector. Additionally, Micro-X engages in partnerships and collaborations with industry leaders to enhance its product offerings and expand its market reach. The company's earnings are further supported by ongoing research and development efforts aimed at broadening its product portfolio and maintaining a competitive edge in the rapidly evolving imaging technology market.

Micro-X Ltd. Financial Statement Overview

Summary

Micro-X Ltd. is experiencing growth in revenue but faces significant challenges in achieving profitability and positive cash flow. The balance sheet shows stability with a low leverage position, although the lack of profitability impacts return metrics. The company needs to improve operational efficiency and cash generation to enhance its financial health.

Income Statement

Micro-X Ltd. has shown a moderate revenue growth rate of 1.45% over the past year, reflecting a slight improvement. However, the company is still facing challenges in terms of profitability, with negative net and gross profit margins. The EBIT and EBITDA margins are also negative, indicating operational difficulties in achieving profitable growth.

Balance Sheet

The company has a relatively low debt-to-equity ratio of 0.28, suggesting conservative leverage, which is a positive. However, the return on equity is negative due to net losses, indicating inefficiencies in generating returns from shareholders' equity. The equity ratio of 53.03% highlights a stable capital structure with a significant portion of assets financed by equity.

Cash Flow

Micro-X Ltd. shows negative free cash flow growth, highlighting ongoing challenges in generating positive cash flow. The operating cash flow to net income ratio is negative, indicating struggles in converting operations into cash. However, the company has managed to secure financing, which provides some liquidity support.

Breakdown	TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	14.43M	15.22M	15.01M	8.97M	3.77M	4.25M
Gross Profit	6.19M	5.74M	-7.11M	-12.33M	-12.96M	-7.69M
EBITDA	-15.75M	-14.35M	-14.71M	-19.02M	-13.61M	-9.29M
Net Income	-10.78M	-9.77M	-10.75M	-17.09M	-14.73M	-10.07M
Balance Sheet
Total Assets	19.96M	26.89M	30.30M	31.28M	44.68M	33.70M
Cash, Cash Equivalents and Short-Term Investments	2.39M	3.23M	5.22M	10.30M	30.14M	18.32M
Total Debt	5.18M	3.99M	4.77M	5.38M	5.90M	13.54M
Total Liabilities	13.85M	12.63M	13.17M	12.05M	10.53M	18.96M
Stockholders Equity	6.10M	14.26M	17.13M	19.22M	34.15M	14.74M
Cash Flow
Free Cash Flow	-9.22M	-6.80M	-11.77M	-19.22M	-10.76M	-11.65M
Operating Cash Flow	-9.07M	-6.43M	-10.99M	-18.11M	-9.86M	-9.46M
Investing Cash Flow	-152.00K	-369.00K	-779.00K	-1.11M	-901.00K	-2.20M
Financing Cash Flow	6.31M	4.81M	6.69M	-612.00K	22.57M	28.37M

Micro-X Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:MX1, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.05, and below the 200-day MA of 0.07, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 36.52 is Neutral, neither overbought nor oversold. The STOCH value of -7.41 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:MX1.

Micro-X Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CSX	54 Neutral	AU$38.33M	―	-7.59%	―	28.89%	72.95%
Sector *	52 Neutral	$7.53B	0.32	-61.76%	2.28%	16.60%	1.56%
CYC	49 Neutral	AU$123.92M	―	-35.20%	―	4.68%	-155.42%
EMV	46 Neutral	AU$149.65M	―	-58.61%	―	―	-74.88%
MX1	44 Neutral	AU$30.02M	―	-135.33%	―	-27.58%	33.69%
CBL	39 Underperform	AU$9.43M	―	-98.08%	―	-7.44%	30.34%
4DX	39 Underperform	AU$114.06M	―	-52.37%	―	471.29%	-4.58%

Micro-X Ltd. Corporate Events

Micro-X Ltd Achieves Key Development Milestones in Health and Security Projects

Micro-X Ltd has successfully achieved significant development milestones on time and within budget for its contracts with ARPA-H and Billion Prima, enhancing its position in the health and security markets. The company completed Milestone 3 for a Full Body CT scanner under its ARPA-H contract and Milestone 2 for a baggage and parcel scanning unit with Billion Prima. These achievements underscore Micro-X’s commitment to timely project delivery and its strategic partnerships, which are crucial for its growth and market expansion.

The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.

Micro-X Ltd. Appoints New Company Secretary to Enhance Growth

Micro-X Ltd. has announced the appointment of Mr. Richard Willson as the new Company Secretary, effective May 30, 2025. Mr. Willson brings over 25 years of experience in the technology and resources sectors, with a strong background in corporate governance and financial management. This strategic appointment is expected to strengthen Micro-X’s corporate governance and support its growth ambitions in the health and security markets. The company continues to innovate in x-ray technology and expand its market presence, with significant projects underway in both healthcare and security sectors.

The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.

Micro-X Ltd. Announces Quotation of New Securities on ASX

Micro-X Ltd. has announced the quotation of 171,819 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code MX1, effective from May 15, 2025. This move is part of an employee incentive scheme and reflects the company’s ongoing efforts to enhance its market presence and operational capabilities.

The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.

Micro-X Ltd. Director Increases Stake Through Share Placement

Micro-X Ltd. announced a change in the director’s interest, with Patrick O’Brien acquiring 1,428,571 ordinary shares, increasing his total holdings to 10,287,591 shares. This acquisition was made through a company placement approved by shareholders, reflecting confidence in the company’s strategic direction and potential growth, which could impact stakeholders positively by enhancing market confidence.

Micro-X Director Increases Stake with Significant Share Acquisition

Micro-X Ltd. announced a change in the director’s interest, with Ilona Meyer acquiring 357,143 ordinary shares through a company placement approved by shareholders. This acquisition increases Meyer’s total holdings to 567,961 fully paid ordinary shares, indicating a significant investment in the company’s future, potentially impacting its market positioning and stakeholder confidence.

Micro-X Director Increases Stake, Signaling Confidence in Growth

Micro-X Ltd. announced a change in the director’s interest, with Jim McDowell acquiring 714,286 ordinary shares through the company’s placement approved at the Extraordinary General Meeting in April 2025. This acquisition increases McDowell’s indirect holding, indicating a vote of confidence in the company’s strategic direction and potential growth, which could positively impact stakeholders and market perception.

Micro-X Director Increases Stake with Share Acquisition

Micro-X Ltd. announced a change in the director’s interest, with Director Andrew Hartmann acquiring 357,143 fully paid ordinary shares valued at $25,000. This acquisition was part of a company placement approved by shareholders, potentially strengthening the director’s alignment with company interests and signaling confidence in Micro-X’s future growth.

Micro-X Ltd. Announces Quotation of New Securities on ASX

Micro-X Ltd. has announced the quotation of 2,857,143 ordinary fully paid securities on the Australian Securities Exchange (ASX) with the code MX1, set to be issued on May 8, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and provide additional capital for its operations, potentially impacting its industry positioning and stakeholder interests.

Micro-X Ltd. Approves Key Resolutions at Extraordinary General Meeting

Micro-X Ltd. held an Extraordinary General Meeting on April 16, 2025, where several resolutions regarding the ratification and approval of the issuance of placement shares were passed. These resolutions, which received overwhelming support, are part of the company’s strategic initiatives to strengthen its financial position and expand its market presence.

Micro-X Ltd. Announces Cessation of Performance Rights

Micro-X Ltd. announced the cessation of 1,167,220 performance rights due to the lapse of conditional rights that were not satisfied. This cessation may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s operational performance and strategic execution.